BEDFORD, Mass., /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced that David LaVance has resigned as Chairman of the Company's Board of Directors, and notified the Board that he will not stand for re-election at the 2016 Annual Meeting of Stockholders.

Steve MacMillan, Hologic's President and Chief Executive Officer, has been appointed Chairman of the Board.  In addition, current Director Elaine Ullian, retired President and Chief Executive Officer of the Boston Medical Center, has been appointed Lead Independent Director.  Ullian has been a member of the Company's Board since 2007.

"It has been a great honor to contribute to Hologic's growth and development since 2002," LaVance said.  "The Company's future is bright, so this is the right time for me to transition leadership to the experienced team that's now in place."

"I'd like to thank David for his many contributions to Hologic over 13 years of distinguished service, and for his partnership in building a board and management team capable of delivering sustainable growth across the company," MacMillan said.

Source credit: Hologic, Inc.

«« Ensuring Radiation Safety in Clinical Trials


Cell Density Unchanged as Brain Shrinks With Age »»



Latest Articles

mammography, radiology, imaging, hologic BEDFORD, Mass., /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced that David LaVance has resigned as Chairman of the Company's Board of Directors, an...